为患有喘的儿童提供家庭教育干预措施.
Antonia O'Connor1,2, Maryam Hasan3, Krishna Bajee Sriram4,5
1Department of Respiratory and Sleep Medicine, Women's and Children's Hospital, North Adelaide, Australia.
The Cochrane database of systematic reviews
|February 6, 2025
概括
与其他地方通常的护理或教育相比,家庭喘教育对儿童的益处是不确定的. 虽然它可能会略有改善生活质量,但需要更多的研究来确定喘管理的最佳内容和有效性.
科学领域:
- 儿科肺病学 儿科肺病学
- 健康 教育 研究 研究 教育 研究
- 基于证据的医学基于证据的医学.
背景情况:
- 喘是一种普遍的慢性呼吸道疾病,影响全球数百万人.
- 基于家庭的喘教育旨在改善熟悉环境中的自我管理技能.
- 现有证据表明,家庭喘教育的优越性需要进一步调查.
研究的目的:
- 评估儿童喘家庭教育干预措施的有效性.
- 评估对儿童,护理人员或两者的喘相关结果的影响.
- 为了比较家庭教育与通常的护理,不那么密集的教育或在其他地方提供的教育.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 为患有喘的儿童 (2-18岁) 提供面对面的自我管理计划.
- 使用GRADE的数据提取和质量评估;连续和二分法数据的元分析.
主要成果:
- 与对照组相比,家庭教育对急诊室的访问产生了非常不确定的影响,并且对口服皮质类固醇使用的确定性很低.
- 观察到生活质量得分的潜在改善,尽管有非常不确定的证据.
- 较为密集的家庭教育并没有显著减少紧急诊所,但与较少密集的计划相比,可能会减少住院治疗.
结论:
- 与在其他环境中提供的通常护理或教育相比,家庭喘教育干预措施的证据仍然不确定.
- 家庭教育可能为生活质量带来好处,并可能减少住院治疗.
- 研究中的大量多样性限制了解释;需要进一步的研究来确定儿童喘教育的最佳组件和设置.
相关概念视频
01:30Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:23Inhaled Medications
220
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
220
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
233
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
233